Effect of AFQ056 for people Diagnosed With OCD and Resistant to SSRI Treatment; Failed SSRI Over 12 Weeks at Appropriate Doses
Understand this study
Who could participate?
This study is for people with OCD. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
- Listed locations
- San Diego and 14 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 50
- Sponsor
- Novartis Pharmaceuticals
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States, Switzerland, Bulgaria, ...
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01813019
- Official title
Show the full official title
A Randomized, Double-blind, Placebo-controlled, Parallel-group Proof of Concept Study to Evaluate the Effect of AFQ056 in Obsessive Compulsive Disorder (OCD) Patients Resistant to Selective Serotonin Reuptake Inhibitor (SSRI) Therapy
Recruitment & locations
San Diego, United States · Watertown, United States · Brooklyn, United States
12 more locations
- Burgas, Bulgaria
- Pazardzhik, Bulgaria
- Sofia, Bulgaria
- Varna, Bulgaria
- Strakonice, Czechia
- Berlin, Germany
- Freiburg im Breisgau, Germany
- München, Germany
- Nuremberg, Germany
- Ulm, Germany
- Bern, Switzerland
- Czechia
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Novartis Pharmaceuticals.
Does this study involve medication?
Yes. The study involves medication, including AFQ056 and Placebo.
Who can participate?
This study is for people with OCD. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
